gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide has been researched along with Hepatitis B, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, F; Duan, Z; Jiang, J; Li, J; Li, L; Li, Y; Liu, J; Liu, M; Song, Y; Wang, J; Xiao, Y; Zhai, X; Zhang, X; Zhu, L; Zhuang, H; Zou, H | 1 |
| Chabot, S; Cui, Q; Gimie, Y; Kachko, A; Major, M; Murphy, T; Schillie, S; Zhao, Y; Zubkova, I | 1 |
| Alleman, MM; Biey, J; Bwaka, AM; Impouma, B; Kabore, HJ; Li, X; Manzengo, CM; Mumba, M; Paluku, G; Tohme, RA | 1 |
3 other study(ies) available for gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and Hepatitis B, Chronic
| Article | Year |
|---|---|
A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections.
Topics: Child; Child, Preschool; DNA, Viral; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infant; Postoperative Complications; Prospective Studies | 2022 |
Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine during co-administration.
Topics: Animals; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Immunoglobulins; Mice | 2023 |
Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - World Health Organization African Region, 2016-2021.
Topics: Child, Preschool; COVID-19; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Pandemics; Seroepidemiologic Studies; World Health Organization | 2023 |